Position in KURA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,348,015
-$1,388,172 QoQ
Shares Held
411,810
-9.7% QoQ
Ownership
0.464%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SECTOR GAMMA AS holds $86,205,288 across 14 Biotechnology names. KURA ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
200,510 | $18,872,001 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
239,918 | $13,552,967 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
169,468 | $12,725,352 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
286,007 | $6,681,123 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
75,000 | $5,109,750 | |
| 6 | ASND |
Ascendis Pharma A/S
|
21,305 | $4,873,092 | |
| 7 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
94,195 | $3,421,162 | |
| 8 | KURA |
Kura Oncology, Inc.
This page
|
411,810 | $3,348,015 |
All Filings in KURA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,348,015 | 411,810 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,736,187 | 455,841 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,879,972 | 438,415 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||